Published date: 12 December 2019

Last edited date: 12 December 2019

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 19 December 2019

Contract summary

Industry

  • Immunoassay analysers - 38434580

Location of contract

South East

Value of contract

£20,000

Procurement reference

tender_227416/819517

Published date

12 December 2019

Closing date

19 December 2019

Contract start date

20 December 2019

Contract end date

31 December 2020

Contract type

Supply contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

Public Health England (PHE) is seeking to procure single cell western blot equipment its Centre for Radiation, Chemical and Environmental Hazards (CRCE).
The equipment will be used to research the processes underpinning radiation-induced cardiovascular disease. The current \"safe-level\" of exposure to radiation that is permissible, is based solely on radiation doses that can cause cancers. However, it is becoming increasingly clear that cancer may not be the only disease that can be induced by radiation. Cardiovascular disease is at the top of the list of potential non-cancer ailments that can be instigated by radiation.

The single cell western blot equipment must meet the following mandatory requirements:
- The system must be capable of microscale separations, quantitation, and immunodetection of proteins in single-cells and must be able to analyse around 1000 single cells per run.
- The system must be compatible with conventional western primary antibodies and standard fluorescently tagged secondary antibodies for immune-probing.
- The instrument must have capability of multiplexing at least 2 target proteins per run and must offer possibility of stripping and reprobing with different set of antibodies.
- The analysis software must perform automatic detection of lanes and protein peaks and offer automatic peak quantification.
Desirable requirement:
- Bench-top footprint would be advantage

If you feel that you can meet the above requirements please login / register on PHE eSourcing https://phe.bravosolution.co.uk/web/login.shtml to access the tender documents


More information

Links


About the buyer

Address

133-155 Waterloo Road
London
SE1 8UG
England

Email

anna.gibson@phe.gov.uk